Abstract
To assess current use of vancomycin for methicillin-resistant Staphylococcus aureus bacteremia, we surveyed adult infectious disease physicians. Most respondents reported personal experience with infections failing to respond to vancomycin despite minimum inhibitory concentration data indicating susceptibility. In a hypothetical case of such an infection, most would change to daptomycin with or without other agents.
Original language | English |
---|---|
Journal | Open Forum Infectious Diseases |
Volume | 5 |
Issue number | 5 |
DOIs | |
State | Published - 1 May 2018 |
Externally published | Yes |
Keywords
- Bacteremia
- GSSA
- MRSA
- Treatment failure
- Vancomycin